MannKind Corp. (MNKD)
3.29
-0.13
(-3.80%)
USD |
NASDAQ |
Oct 09, 16:00
3.30
+0.01
(+0.30%)
After-Hours: 20:00
MannKind Free Cash Flow (Quarterly) : -23.71M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -23.71M |
| March 31, 2026 | -7.524M |
| December 31, 2025 | -9.422M |
| September 30, 2025 | 22.36M |
| June 30, 2025 | 7.657M |
| March 31, 2025 | -6.907M |
| December 31, 2024 | 19.63M |
| September 30, 2024 | 7.835M |
| June 30, 2024 | 0.759M |
| March 31, 2024 | 4.194M |
| December 31, 2023 | 15.75M |
| September 30, 2023 | -2.745M |
| June 30, 2023 | -14.32M |
| March 31, 2023 | -7.227M |
| December 31, 2022 | -7.49M |
| September 30, 2022 | -28.34M |
| June 30, 2022 | -29.15M |
| March 31, 2022 | -23.30M |
| December 31, 2021 | -17.54M |
| September 30, 2021 | -19.43M |
| June 30, 2021 | -22.50M |
| March 31, 2021 | -13.71M |
| December 31, 2020 | -0.262M |
| September 30, 2020 | -13.46M |
| June 30, 2020 | -3.834M |
| Date | Value |
|---|---|
| March 31, 2020 | -11.37M |
| December 31, 2019 | -5.216M |
| September 30, 2019 | -53.01M |
| June 30, 2019 | -20.95M |
| March 31, 2019 | -11.87M |
| December 31, 2018 | 24.63M |
| September 30, 2018 | -13.92M |
| June 30, 2018 | -27.15M |
| March 31, 2018 | -21.65M |
| December 31, 2017 | -29.98M |
| September 30, 2017 | -23.27M |
| June 30, 2017 | -20.03M |
| March 31, 2017 | 8.507M |
| December 31, 2016 | -12.75M |
| September 30, 2016 | -23.07M |
| June 30, 2016 | -11.51M |
| March 31, 2016 | -31.90M |
| December 31, 2015 | -23.69M |
| September 30, 2015 | -21.12M |
| June 30, 2015 | -22.34M |
| March 31, 2015 | -1.183M |
| December 31, 2014 | -40.71M |
| September 30, 2014 | 90.77M |
| June 30, 2014 | -31.68M |
| March 31, 2014 | -38.40M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| United Therapeutics Corp. | 202.20M |
| ACADIA Pharmaceuticals, Inc. | 95.69M |
| Gilead Sciences, Inc. | 3.433B |
| Vertex Pharmaceuticals, Inc. | 1.013B |
| Ocugen, Inc. | -12.22M |